ARTICLE | Finance
Talecris takeout, again
$3.4B Grifols-Talecris deal is windfall for Cerberus chief
June 14, 2010 7:00 AM UTC
Investors in the October 2009 IPO by Talecris Biotherapeutics Inc. (NASDAQ:TLCR) will get their initial investment back in cash, plus a bit tacked on in shares, under a takeout bid from fellow plasma company Grifols S.A. (Madrid:
GRF)...